Leadership
We are a mission-driven and multidisciplinary team of physicists, molecular biologists, geneticists, epidemiologists, computer scientists, chemists, clinicians, drug developers, and entrepreneurs focused on the development and application of AI to patient data to radically transform the discovery and development of new drugs, and ultimately change the way we treat and eventually cure diseases.
Board of Directors
John Maraganore, PhD
Chair of Aitia Board of Directors, Venture Partner at ARCH Venture Partners, Venture Advisor at Atlas Ventures, Executive Partner at RTW Investments. Former founding CEO and Director of Alnylam.
Adrian Weller, PhD
Senior Research Fellow, University of Cambridge Programme Director, Artificial Intelligence, The Alan Turing Institute
Board Observers
Advisors
Lee Newcomer
Board member of Myriad Genetics and CellWorks
Former Senior Vice President, Oncology and Genetics, and Chief Medical Officer at UnitedHealth Group
Ravi B. Parikh, MD, MPP, FACP
Aitia Chief Oncology Advisor
Oncologist and Faculty Member at University of Pennsylvania & Board of Directors at Coalition to Transform Advanced Care
Our Investors








